Skip to content
Home/Companies/Biotech/Atrandi Biosciences
Atrandi Biosciences

Atrandi Biosciences

Biotech·Lithuania·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Atrandi Biosciences?

Atrandi Biosciences is a Lithuanian Biotech company, currently owned by Vsquared Ventures since 2025.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
Vsquared Ventures
Investor
Vsquared Ventures
Vsquared Ventures II · 2024 · VC

Key facts

HQLithuania
SectorBiotech
StatusActive
Websiteatrandi.com

More from Vsquared Ventures II

Other portfolio companies in the same fund.

Arlequin AI
Active
SoftwareFrance· 2025
Belfort
Belfort
Active
Deep TechBelgium· 2025
Hedera Dx
Hedera Dx
Active
MedTechSwitzerland· 2025
Pulsetrain
Active
MobilityGermany· 2025
Cylib
Cylib
Active
ClimateTechGermany· 2024
Kano Therapeutics
Kano Therapeutics
Active
BiotechUS· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Atrandi Biosciences?

Atrandi Biosciences is currently owned by Vsquared Ventures, through Vsquared Ventures II, since 2025.

When did Vsquared Ventures acquire Atrandi Biosciences?

Vsquared Ventures acquired Atrandi Biosciences in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue